<DOC>
	<DOCNO>NCT02691455</DOCNO>
	<brief_summary>Outcomes subject uncontrolled glaucoma single exist aqueous tube shunt implant undergoing second aqueous shunt transscleral diode laser cyclophotocoagulation .</brief_summary>
	<brief_title>The AGS Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study ( ASSISTS )</brief_title>
	<detailed_description>This study compare short- ( 1 year ) , mid- ( 3 year ) , long-term ( 5 year ) cumulative incidence failures participant undergo second aqueous shunt ( SAS ) cumulative incidence failures participant undergo second aqueous shunt ( SAS ) cumulative incidence failures participant undergo transscleral diode laser cyclophotocoagulation ( TLC ) eye uncontrolled glaucoma single exist aqueous tube shunt procedure .</detailed_description>
	<criteria>Women men 40 85 year age Glaucoma adequately control ( IOP &gt; 18 mmHg maximum tolerate topical therapy ) single aqueous shunt ( AS ) . Bestcorrected visual acuity ( BCVA ) hand motion ( HM ) good study eye Monocular Presence one AS study eye Previous cyclodestruction study eye Presence active iris neovascularization study eye Binocular diplopia Presence scleral buckle study eye History scleritis either eye History scleromalacia study eye Insufficient conjunctiva cover AS study eye IOP accurately measure Goldmann applanation , Pneumotonometry , TonoPen study eye Presence silicone oil study eye Presence retinal detachment study eye Presence intraocular orbital tumor affect study eye Need cataract extraction concurrent procedure time study treatment , except tectonic aqueous shunt revision group allow . In opinion investigator , enrol study Unwilling unable give consent satisfy requirement study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>